Financial toxicity and implications for cancer care in the era of molecular and immune therapies.
Publication
, Journal Article
Tran, G; Zafar, SY
Published in: Ann Transl Med
May 2018
Molecular and immune therapies have revolutionized cancer treatment and improved patient outcomes and survival. However, the pricing of these drugs has become an issue as the cost of cancer care continues to rise significantly. Cost sharing policies have increased out-of-pocket expenses for patients, leading to poorer financial well-being, quality of life, psychosocial health, and treatment adherence. In this review, we briefly examine some factors affecting the pricing of these new targeted therapies; the effects of financial toxicity on patients; and highlight potential health policy and patient-provider level interventions to address these issues.
Duke Scholars
Published In
Ann Transl Med
DOI
ISSN
2305-5839
Publication Date
May 2018
Volume
6
Issue
9
Start / End Page
166
Location
China
Related Subject Headings
- 42 Health sciences
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Tran, G., & Zafar, S. Y. (2018). Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med, 6(9), 166. https://doi.org/10.21037/atm.2018.03.28
Tran, George, and S Yousuf Zafar. “Financial toxicity and implications for cancer care in the era of molecular and immune therapies.” Ann Transl Med 6, no. 9 (May 2018): 166. https://doi.org/10.21037/atm.2018.03.28.
Tran G, Zafar SY. Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med. 2018 May;6(9):166.
Tran, George, and S. Yousuf Zafar. “Financial toxicity and implications for cancer care in the era of molecular and immune therapies.” Ann Transl Med, vol. 6, no. 9, May 2018, p. 166. Pubmed, doi:10.21037/atm.2018.03.28.
Tran G, Zafar SY. Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med. 2018 May;6(9):166.
Published In
Ann Transl Med
DOI
ISSN
2305-5839
Publication Date
May 2018
Volume
6
Issue
9
Start / End Page
166
Location
China
Related Subject Headings
- 42 Health sciences
- 32 Biomedical and clinical sciences